A phase 2 study evaluated meaningful activity from lifileucel for patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors. Lifileucel led to ...

J.B. Ward's experience highlights the importance of self-advocacy in managing rare cancers, emphasizing the need for patients to seek multiple opinions and question medical advice. Mucosal melanoma is ...